As a high-grade neuroendocrine carcinoma, LCNEC transformation shared similar clinical features and genomic characteristics with SCLC transformation.[36] Previous studies suggested that the underlying molecules mechanisms of both SCLC and LCNEC transformation may be the loss of Rb1/TP53. This evidence concerns the gene RB1 and small cell lung carcinoma.